S Purswani, GP Talwar, R Vohra, R Pal… - Journal of Reproductive …, 2011 - Elsevier ... for its ability to enhance antibody titers with the recombinantvaccine. In BALB/c mice, the peak titers and duration of antibody response was significantly increased by inclusion of MIP (Purswani and Talwar, 2011). As the immune response varies with the genetic make-up of the ...
[HTML] from plos.orgSA Migueles, JE Rood, AM Berkley, T Guo… - PLoS pathogens, 2011 - dx.plos.org ... HLA class I alleles like B*57 [2]–[8]. In B*57 + LTNP, this genetic association is ... I clinical studies have been the replication incompetent adenovirus serotype 5 (Ad5) HIV-1 recombinant vaccines [22 ... An efficacy trial employing such a vaccine was the Step study, a phase IIB test-of ... Cited by 5 - Related articles - Cached - All 4 versions
[HTML] from nih.govJJ Shao, CK Wong, T Lin, SK Lee… - Clinical and Vaccine …, 2011 - Am Soc Microbiol ... expression system. Fourth, the development of a multiple-epitope recombinantvaccine is easier than that of a traditional inactivated vaccine because of the use of genetic engineering and bioinformatics. Finally, multiple-epitope ... Cited by 3 - Related articles - All 4 versions
NL Letvin, SS Rao, DC Montefiori… - Science …, 2011 - translationalmedicine.org ... We used a nonhuman primate model to define immune and genetic mechanisms of protection against mucosal infection by the simian immunodeficiency virus (SIV). A plasmid DNA prime/recombinant adenovirus serotype 5 (rAd5) boost vaccine regimen was evaluated for its ... Cited by 4 - All 6 versions
J Fellay, N Frahm, KV Shianna… - Journal of Infectious …, 2011 - jid.oxfordjournals.org ... HLA-B*57 is the human genetic factor that has been most consistently associated with potent control of HIV-1 [13–17], with HLAB*5701 observed ... Responses to HIV-1 proteins were measured in samples from ALVAC HIV recombinant canarypox vaccine trials by ... Cited by 2 - Related articles - All 6 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
